CompletedPhase 2

Study to Improve Partner Services for STD Prevention

United States1,500 participantsStarted 2001-12

Plain-language summary

The goal of this study was to examine the efficacy of patient-delivered partner treatment (PDPT) compared to standard partner referral (PR) and booklet enhanced partner referral (BEPR).

Who can participate

Age range

16 Years – 44 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Woman attending Family Planning Clinic or men attending STD clinic * Aged 16-44 * (non-pregnant women) - positive InPouch for trichomonas, or * (pregnant women) - positive wet mount or InPouch for Trichomonas vaginalis * (men) a complaint of urethritis which is verified on examination * Report having \>= 1sex partners in past 60 days * Not presumptively treated for trichomonas (women) or urethritis (men) * Provide informed consent to be re-contacted by telephone or in person in 14-28 days for a follow-up interview and T vaginalis or CT/GC rescreening Exclusion Criteria: Men * Prisoner * Has taken cefixime or azithromycin in last two weeks * Has previously participated in the study * All female partners are pregnant and did not have male partners Women * client has taken metronidazole in the last two weeks * client has been in this study previously * women who are asymptomatic and in their first trimester of pregnancy

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Index patient report of partner taking medicine at 6-8 weeks

Trial details

NCT IDNCT00207467

SponsorCenters for Disease Control and Prevention

Sponsor typeFED

Study typeINTERVENTIONAL

View on ClinicalTrials.gov More Trichomonas Vaginalis trials

Who can participate

Age range

16 Years – 44 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.